HRT Financial’s Heart Test Laboratories HSCS Stock Holding History

HRT Financial’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,166	Closed	-$48K	–	2749
2024 Q3	$48K	Buy	+10,166	New	+$37.2K	﹤0.01%	2109
2024 Q2	–	Sell	-1,225	Closed	-$14K	–	2582
2024 Q1	$14K	Buy	+1,225	New	+$16K	﹤0.01%	2039
2023 Q4	–	Sell	-199	Closed	-$8K	–	2638
2023 Q3	$8K	Buy	199 +79	+66%	+$6.13K	﹤0.01%	2141
2023 Q2	$10K	Buy	+120	New	+$11.7K	﹤0.01%	2171

Other funds holding HSCS

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's HSCS Position: Q4 2024 in Review

HRT Financial sold out of Heart Test Laboratories (HSCS) in Q4 2024, closing a stake of 10,166 shares — an estimated $48K sold.

HRT Financial first reported a position in HSCS in Q2 2023 and held it in 4 quarters. The position peaked at $48K in Q3 2024. 3 funds tracked by Wall St. Rank hold HSCS as of Q4 2024.

HRT Financial reported no remaining Heart Test Laboratories position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 10,166 Heart Test Laboratories shares in Q4 2024, an estimated $48K.
HRT Financial first reported a position in Heart Test Laboratories in Q2 2023 and held it in 4 quarters.
HRT Financial's Heart Test Laboratories position peaked at $48K in Q3 2024.
3 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.